The Hydration Pharmaceuticals Co (ASX:HPC) EBITDA Margin %: -112.75% (As of Dec. 2025)


What is The Hydration Pharmaceuticals Co EBITDA Margin %?

The Hydration Pharmaceuticals Co ASX:HPC -20.00% EBITDA Margin % is -112.75% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 310 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 98.06% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Hydration Pharmaceuticals Co's EBITDA for the six months ended in Dec. 2025 was A$-2.50 Mil. The Hydration Pharmaceuticals Co's Revenue for the six months ended in Dec. 2025 was A$2.22 Mil. Therefore, The Hydration Pharmaceuticals Co's EBITDA margin for the quarter that ended in Dec. 2025 was -112.75%.


The Hydration Pharmaceuticals Co  (ASX:HPC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


The Hydration Pharmaceuticals Co EBITDA Margin % Related Terms


The Hydration Pharmaceuticals Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co EBITDA Margin % Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
-86.88 -115.56 -74.29 -122.01 -111.29

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only -81.69 -44.78 2,102.75 -109.14 -112.75

ASX:HPC vs SYY, USFD, PFGC: EBITDA Margin % Comparison

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Hydration Pharmaceuticals Co EBITDA Margin % vs Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's EBITDA Margin % falls into.



The Hydration Pharmaceuticals Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Hydration Pharmaceuticals Co's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.14/3.72
=-111.29 %

The Hydration Pharmaceuticals Co's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.503/2.22
=-112.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -112.75% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a EBITDA Margin % of -112.75% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #304 out of 310 companies in the Retail - Defensive industry, placing it in the top 98.1%.
Is The Hydration Pharmaceuticals Co's EBITDA Margin % too high?
The Hydration Pharmaceuticals Co's current EBITDA Margin % is -112.75%. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #304 out of 310 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's EBITDA Margin % compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #304 out of 310 companies for EBITDA Margin %. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median EBITDA Margin % is 6.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Retail - Defensive company?
The median EBITDA Margin % among Retail - Defensive companies is 6.08, based on 310 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median EBITDA Margin % is 6.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current EBITDA Margin % is -112.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current EBITDA Margin % of -112.75%. The current EBITDA Margin % is -112.75%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current EBITDA Margin % is -112.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.